Medaus Recalls Lidocaine 2% Vials Due to Sterility Concerns
Medaus, Inc. is recalling Lidocaine 2% (PF) in NaCl 10mL vials due to a lack of assurance of sterility. The product was distributed in the U.S., Japan, and New Zealand.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a drug with a sterility defect (which implies a risk of infection) falls under the 'Severe' category, as it is not a Class I recall but involves a significant potential health risk.
Plain-English summary
Medaus, Inc. is recalling Lidocaine 2% (PF) in NaCl, 10mL vials, manufactured by Medaus Pharmacy. The recall was initiated because of a lack of assurance of sterility. The affected product includes specific lots with expiration dates ranging from May 31, 2016, to August 29, 2016.
The recalled vials were distributed nationwide in the United States, as well as in Japan and New Zealand. The total quantity involved is 147 mL in vials.
Consumers and healthcare providers should stop using the affected product and contact Medaus, Inc. for further instructions or a return. This recall is classified as Class II by the FDA, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY
- Manufacturer
- Medaus, Inc.
- Category
- Drug — Injectable Anesthetic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot #: 151203-48
- BUD: 05/31/16
- Lot #: 151204-9
- BUD: 06/01/16
- Lot #: 151218-20
- BUD: 06/15/16
- Lot #: 160125-23
- BUD: 07/23/16
- Lot #: 160125-24
- Lot #: 160125-25
- Lot #: 160127-6
- BUD: 07/25/16
- Lot #: 160302-76
- BUD: 08/29/16
- Lot #: 160302-77
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 88 recalled by Medaus, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 88 products in this recall →Related recalls
Same manufacturer · Medaus, Inc.
See all →- SevereMedaus Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Taurine Vials Due to Lack of Sterility Assurance
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Lipo-Injection Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29